A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
Recruiting · NCT06319456 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL. | chronic lymphocytic leukemia/small lymphocytic lymphoma | Recruiting | Phase 3 | 2026-07-28 | NCT06319456 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangdong Provincial People's Hospital | Guangzhou | China | 85 |
| Hematology Hospital of the Chinese Academy of Medical Sciences | Tianjin | China | 4 |
| Henan Provincial Cancer Hospital | Zhengzhou | China | 5 |
| Hunan Cancer Hospital | Changsha | China | 27 |
| Nanfang Hospital of Southern Medical University | Guangzhou | China | 37 |
| The affiliated Hospital of Guangdong Medical University | Zhanjiang | China | 1 |
| The First Affiliated Hospital of Bengbu Medical College | Bengbu | China | 14 |
| The Second Xiangya Hospital of Center South University | Changsha | China | 1 |
| Tongji Hospital of Tongji University | Shanghai | China | 12 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 7 |